Literature DB >> 26101563

Inhibition of Cathepsin K: A Novel and Promising Treatment for Osteoporosis.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2015        PMID： 26101563      PMCID： PMC4468399          DOI： 10.1021/acsmedchemlett.5b00189

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Cathepsin K inhibitors: a novel target but promising approach in the treatment of osteoporosis.

Authors:  Asadul Mazid Helali; Farhana Matin Iti; Isa Naina Mohamed
Journal:  Curr Drug Targets       Date:  2013-12       Impact factor: 3.465

Review 2.  Cathepsin K: a unique collagenolytic cysteine peptidase.

Authors:  Marko Novinec; Brigita Lenarčič
Journal:  Biol Chem       Date:  2013-09       Impact factor: 3.915

Review 3.  Involvement of cysteine proteases in cancer.

Authors:  Jerzy Góra; Rafal Latajka
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 4.  New therapeutics for osteoporosis.

Authors:  Kong Wah Ng; T John Martin
Journal:  Curr Opin Pharmacol       Date:  2014-03-31       Impact factor: 5.547
  4 in total
  3 in total

1.  Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity.

Authors:  Rui Guo; Yinan Hua; Jun Ren; Karin E Bornfeldt; Sreejayan Nair
Journal:  Cell Death Dis       Date:  2018-06-07       Impact factor: 8.469

Review 2.  Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers.

Authors:  Die Qian; Lisha He; Qing Zhang; Wenqing Li; Dandan Tang; Chunjie Wu; Fei Yang; Ke Li; Hong Zhang
Journal:  Curr Oncol       Date:  2022-08-22       Impact factor: 3.109

3.  The Potential Role of Cathepsin K in Non-Small Cell Lung Cancer.

Authors:  Hui Yang; Jasmine Heyer; Hui Zhao; Shengxian Liang; Rui Guo; Li Zhong
Journal:  Molecules       Date:  2020-09-10       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.